Ratio of Pro-Resolving and Pro-Inflammatory Lipid Mediator Precursors as Potential Markers for Aggressive Periodontitis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zein Elabdeen, Hager R ^a   Mustafa, Manal ^a   Szklenar, Monika ^b   Rühl, Ralph ^b,c   Ali, Raouf ^d   Bolstad, Anne Isine ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b Paprika Bioanalytics Bt   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d University of Science and Technology   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; RESOLVIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GINGIVITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MALE; SALIVA LEVEL; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGGRESSIVE PERIODONTITIS; BIOLOGICAL MARKERS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPOXYGENASE; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SALIVA; YOUNG ADULT;

EID: 84881504013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070838     Document Type: Article

References (45)

1. Armitage GC, (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4: 1-6.
2. Page RC, Kornman KS, (1997) The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14: 9-11.
3. Kornman KS, (2008) Mapping the pathogenesis of periodontitis: a new look. J Periodontol 79: 1560-1568.
4. Offenbacher S, Barros SP, Beck JD, (2008) Rethinking periodontal inflammation. J Periodontol 79: 1577-1584.
5. Meng H, Ren X, Tian Y, Feng X, Xu L, et al. (2011) Genetic study of families affected with aggressive periodontitis. Periodontol 2000 56: 87-101.
6. Laine ML, Crielaard W, Loos BG, (2012) Genetic susceptibility to periodontitis. Periodontol 2000 58: 37-68.
7. Van Dyke TE, Serhan CN, (2003) Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82: 82-90.
8. Serhan CN, Yacoubian S, Yang R, (2008) Anti-inflammatory and proresolving lipid mediators. Ann Rev Pathol 3: 279-312.
9. Yamada T, Tani Y, Nakanishi H, Taguchi R, Arita M, et al. (2011) Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 25: 561-568.
10. Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, et al. (2011) Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PloSOne 6: e24422 24421-24429.
11. Inada M, Matsumoto C, Uematsu S, Akira S, Miyaura C, (2006) Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J Immunol 177: 1879-1885.
12. Buczynski MW, Dumlao DS, Dennis EA, (2009) Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50: 1015-1038.
13. Calder PC, (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S.
14. Tsai CC, Hong YC, Chen CC, Wu YM, (1998) Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 26: 97-103.
15. Offenbacher S, Odle BM, Gray RC, Van Dyke TE, (1984) Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodontal Res 19: 1-13.
16. Yamamoto S, (1992) Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128: 117-131.
17. Boeglin WE, Kim RB, Brash AR, (1998) A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci U S A 95: 6744-6749.
18. Sigal E, Craik CS, Highland E, Grunberger D, Costello LL, et al. (1988) Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun 157: 457-464.
19. Sigal E, Grunberger D, Craik CS, Caughey GH, Nadel JA, (1988) Arachidonate 15-lipoxygenase (omega-6 lipoxygenase) from human leukocytes. Purification and structural homology to other mammalian lipoxygenases. J Biol Chem 263: 5328-5332.
20. Brash AR, Boeglin WE, Chang MS, (1997) Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci U S A 94: 6148-6152.
21. Kuhn H, Thiele BJ, (1999) The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 449: 7-11.
22. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B, (2000) Serum fatty acid imbalance in bone loss: example with periodontal disease. Clin Nutr 19: 271-276.
23. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN, (2000) Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochem 39: 4761-4768.
24. Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B, (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostag Oth Lipid M 97: 73-82.
25. Serhan CN, Chiang N, Van Dyke TE, (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
26. Serhan CN, Chiang N, (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153Suppl 1: S200-215.
27. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, et al. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206: 15-23.
28. Schwab JM, Chiang N, Arita M, Serhan CN, (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.
29. Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, et al. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 179: 7021-7029.
30. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, et al. (2010) Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol 81: 1635-1643.
31. Zhang A, Sun H, Wang P, Han Y, Wang X, (2012) Modern analytical techniques in metabolomics analysis. The Analyst 137: 293-300.
32. Figueredo CM, Martinez GL, Koury JC, Fischer RG, Gustafsson A, (2013) Serum Levels of Long-chain Polyunsaturated Fatty Acids in Patients with Periodontal Disease. J Periodontol 84: 675-82.
33. Serhan CN, (1994) Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1212: 1-25.
34. Ji RR, Xu ZZ, Strichartz G, Serhan CN, (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 34: 599-609.
35. Arita M, Oh SF, Chonan T, Hong S, Elangovan S, et al. (2006) Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem 281: 22847-22854.
36. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, et al. (2011) The human serum metabolome. PLoS One 6: e16957.
37. Mas E, Croft KD, Zahra P, Barden A, Mori TA, (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58: 1476-1484.
38. Johnson RD, Polakoski KL, Huang X, Sadovsky Y, Nelson DM, (1998) The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia. Am J Obstet Gynecol 178: 54-58.
39. Pearson T, Zhang J, Arya P, Warren AY, Ortori C, et al. (2010) Measurement of vasoactive metabolites (hydroxyeicosatetraenoic and epoxyeicosatrienoic acids) in uterine tissues of normal and compromised human pregnancy. J Hypertens 28: 2429-2437.
40. Camp RD, Coutts AA, Greaves MW, Kay AB, Walport MJ, (1983) Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol 80: 497-502.
41. Griffiths GS, (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000 31: 32-42.
42. Miyasaki KT, (1991) The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 62: 761-774.
43. Mrsny RJ, Gewirtz AT, Siccardi D, Savidge T, Hurley BP, et al. (2004) Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc Natl Acad Sci U S A 101: 7421-7426.
44. Flachs P, Rühl R, Hensler M, Janovska P, Zouhar P, et al. (2011) Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54: 2626-2638.
45. Szklenar M, Kalkowski J, Stangl V, Lorenz M, Rühl R (2013) Eicosanoids and docosanoids in plasma and aorta of healthy and atherosclerotic rabbits. J Vasc Res. (In press).